He has extensive experience in stereotactic surgery in infants and children and has development programs in many minimally invasive epilepsy surgery techniques at TCH, including MR-guided laser ablation, Responsive Neurostimulation (RNS) and Deep Brain Stimulation (DBS).

He has recently developed the Texas Children’s Hospital Intracerebral Gene Therapy Program with investigations into intraputamenal gene therapy for AADC deficiency, gene therapy for Rett syndrome and NGLI-1 Deficiency. Dr Curry is also the developer and director of the Neuroinfusion Service at TCH, conducting intracerebral enzyme replacement therapy in Batten’s disease and other neurodegenerative diseases.